Cargando…
Real-world effectiveness of a single dose of mpox vaccine in males
The recent global outbreak of the monkeypox (mpox) virus in humans was declared a public health emergency by the World Health Organization in July 2022. The smallpox and mpox vaccine (JYNNEOS; Modified Vaccinia Ankara-Bavarian Nordic; MVA-BN), provided as a two-dose regimen, is currently the primary...
Autores principales: | Wolff Sagy, Yael, Zucker, Roy, Hammerman, Ariel, Markovits, Hila, Arieh, Noa Gur, Abu Ahmad, Wiessam, Battat, Erez, Ramot, Noga, Carmeli, Guy, Mark-Amir, Avner, Wagner-Kolasko, Gal, Duskin-Bitan, Hadar, Yaron, Shlomit, Peretz, Alon, Arbel, Ronen, Lavie, Gil, Netzer, Doron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930701/ https://www.ncbi.nlm.nih.gov/pubmed/36720271 http://dx.doi.org/10.1038/s41591-023-02229-3 |
Ejemplares similares
-
Risk assessment of human mpox infections: retrospective cohort study
por: Zucker, Roy, et al.
Publicado: (2023) -
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study
por: Arbel, Ronen, et al.
Publicado: (2023) -
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge
por: Arbel, Ronen, et al.
Publicado: (2022) -
BNT162b2 Vaccine Booster and Mortality Due to Covid-19
por: Arbel, Ronen, et al.
Publicado: (2021) -
Trends in the Volume and Types of Primary Care Visits during the Two Years of the COVID-19 Pandemic in Israel
por: Miron, Oren, et al.
Publicado: (2022)